NASHVILLE, Tennessee — A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested. Researchers […]

Sofia Spieler, a Boston public relations professional who has been losing weight on Wegovy, said her “snack monster” has essentially disappeared after she’s had a lifelong […]

When Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit […]

The Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug Administration (FDA) will meet on June 10 to discuss the biologics […]

The type 1 diabetes (T1D) research and advocacy organization Juvenile Diabetes Research Foundation has changed its name to “Breakthrough T1D” to emphasize its mission to help […]

Extreme temperatures are linked to an increased risk for stroke mortality, and people who live in low-income parts of the world are disproportionately affected, results of […]

Women who used levonorgestrel-releasing intrauterine devices (LG-IUDs) were 22% less likely to have a stroke than those who did not use hormonal contraception, new research suggested. […]

A reformulation of the multiple cancer drugs in the combination treatment known as BEACOPP boosted progression-free survival vs the original therapy in adult patients with advanced-stage […]

CHICAGO — Osimertinib (Tagrisso) may soon have approvals across all stages of epidermal growth factor receptor (EGFR)–mutated non–small cell lung cancer (NSCLC). The third-generation EGFR tyrosine […]